John A. Pulikkan, PhD, a postdoctoral associate in the laboratory of Lucio H. Castilla, PhD, associate professor in the Program in Gene Function & Expression, received a Young Investigator Award from Alex’s Lemonade Stand Foundation for Childhood Cancer.
Otherwise healthy patients who have mild hypertension are being overtreated, according to an analysis published in The BMJ by UMass Medical School family physicians Stephen Martin, MD, and Marcy Boucher, MD.
The Meyers Primary Care Institute at UMass Medical School is one of 10 sites taking part in a $30 million, five-year intervention study to drastically reduce the number of falls in older adults funded by National Institutes of Health and the Patient Centered Outcomes Research Institute.
The Center for Collaborative Research in Fragile X at UMMS, with a $9.5 million NIH grant, will be led by Professor of Molecular Medicine Joel D. Richter, PhD. Fragile X is the most common form of inherited intellectual and developmental disability. It can affect one in about 4,000 males and one in about 6,000 females.
Victor R. Ambros, PhD, professor of molecular medicine, has been awarded a $3 million 2015 Breakthrough Prize in Life Sciences for his co-discovery of a new world of genetic regulation by microRNAs.
An image created by Paul Odgren, PhD, research associate professor of cell & developmental biology, was among the winners of the 2014 BioArt competition sponsored by the Federation of American Societies of Experimental Biology.
Keith Reimann, DVM, professor of medicine and senior director of product discovery at MassBiologics, has been appointed to the National Institutes of Health Council of Councils.
Nearly 400 hundred members of the UMass Medical School academic community—faculty, staff, students, postdoctoral fellows and guests—gathered at the Lincoln Conference Center at UMass Amherst for the 19th Annual Basic Research/GSBS Retreat on Nov. 3 and 4.
An innovative study by Milagros C. Rosal, PhD, found that it is feasible to deliver a group diabetes self-management intervention to patients with uncontrolled diabetes via an online "virtual community."
Opioid addiction can be treated successfully with medication, and state policies should reflect the scientific evidence that supports those findings, Robin Clark, PhD, writes in an op-ed for Commonwealth Magazine.